You are viewing the site in preview mode

Skip to main content

Table 1 Patient background characteristics (n = 99)

From: Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study

Age (years) 70.0 (42–90)
Male, n (%) 61 (61.6)
Etiology  
 HBV, n (%) 18 (18.2)
 HCV (including SVR), n (%) 52 (52.5)
 NBNC, n (%) 29 (29.3)
Taking BCAA, n (%) 28 (28.3)
Taking diuretic, n (%) 25 (25.3)
Alcohol, n (%) 39 (39.4)
Diabetes, n (%) 33 (33.3)
HCC, n (%) 70 (70.7)
Esophageal or gastric varices, n (%) 40 (40.4)
Porto-systemic shunts, n (%) 35 (35)
Ascites, n (%) 10 (10.1)
Child–Pugh Class  
 A 60 (60.6)
 B 25 (25.3)
 C 4 (4.0)
Sarcopenia, n (%) 6 (6.1)
Body height (m) 1.59 (1.37–1.90)
Body weight (kg) 57.4 (36.6–92.8)
BMI (kg/m2) 23.7 (16.0–33.9)
Grip strength (kg) 24.6 (7.2–43.5)
Hemoglobin (g/L) 128 (79–169)
Platelets (× 103/μL) 107 (21–390)
ALT (U/L) 23 (8–123)
γ-GTP (U/L) 41 (13–696)
Cholinesterase (U/L) 206 (53–379)
Albumin (g/L) 38 (22–49)
Total cholesterol (mmol/L) 4.16 (2.20–6.59)
Ammonia (mol/L) 31.1 (4.11–157.37)
Prothrombin time (%) 80 (31–115)
Sodium (mEq/L) 140 (133–146)
BCAA (mmol/L) 423.7 (228.3–1459.9)
Tyrosine (mmol/L) 96.2 (37.1–174.0)
BTR 4.75 (1.44–11.07)
Subcutaneous fat area (cm2) 101.61 (3.84–332.49)
Visceral fat area (cm2) 111.37 (7.03–287.84)
CT level of skeletal muscles (HU) 22.70 (− 16.42–47.52)
Skeletal muscle area (cm2) 118.74 (72.12–188.46)
Skeletal muscle index (cm2/m2) 47.9 (29.4–68.5)
Psoas muscle area (cm2) 12.47 (5.11–24.49)
Psoas muscle index (cm2/m2) 5.02 (2.45–9.20)
  1. Continuous variables are expressed as medians. Numbers in parentheses of continuous variables show each range of variables
  2. HBV, hepatitis B virus; HCV, hepatitis C virus; NBNC, non-B, non-C etiology; HCC, hepatocellular carcinoma; BMI, body mass index; ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase; CRP, C-reactive protein; BCAA, branched-chain amino acids; BTR, molar ratio of branched-chain amino acids to tyrosine; CT, computed tomography